About Index Trending news
Analyze
Pricing
REGENXBIO Inc.

REGENXBIO Inc.

REGENXBIO Inc.

REGENXBIO is leading the effort to translate promising gene delivery applications into a pipeline of next generation personalized therapies.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Venture capital (Series D)
$70,500,000
Employees

Team size

50+
Locations
Xconomy

RegenxBio to Acquire Dimension Tx in Combo of Gene Therapy Companies

Health Strategy Science